| Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology N Bertrand, J Wu, X Xu, N Kamaly, OC Farokhzad Advanced drug delivery reviews 66, 2-25, 2014 | 3100 | 2014 |
| The journey of a drug-carrier in the body: an anatomo-physiological perspective N Bertrand, JC Leroux Journal of Controlled Release 161 (2), 152-163, 2012 | 862 | 2012 |
| Cancer nanomedicine: from targeted delivery to combination therapy X Xu, W Ho, X Zhang, N Bertrand, O Farokhzad Trends in molecular medicine 21 (4), 223-232, 2015 | 738 | 2015 |
| Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics N Bertrand, P Grenier, M Mahmoudi, EM Lima, EA Appel, F Dormont, ... Nature communications 8 (1), 1-8, 2017 | 666 | 2017 |
| Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine XQ Zhang, X Xu, N Bertrand, E Pridgen, A Swami, OC Farokhzad Advanced drug delivery reviews 64 (13), 1363-1384, 2012 | 513 | 2012 |
| Engineered nanomedicine for myeloma and bone microenvironment targeting A Swami, MR Reagan, P Basto, Y Mishima, N Kamaly, S Glavey, S Zhang, ... Proceedings of the National Academy of Sciences 111 (28), 10287-10292, 2014 | 298 | 2014 |
| Emerging understanding of the protein corona at the nano-bio interfaces M Mahmoudi, N Bertrand, H Zope, OC Farokhzad Nano Today 11 (6), 817-832, 2016 | 259 | 2016 |
| Hydrophobic Cysteine Poly (disulfide)‐based Redox‐Hypersensitive Nanoparticle Platform for Cancer Theranostics J Wu, L Zhao, X Xu, N Bertrand, WII Choi, B Yameen, J Shi, V Shah, ... Angewandte Chemie International Edition 54 (32), 9218-9223, 2015 | 203 | 2015 |
| Parallel microfluidic synthesis of size-tunable polymeric nanoparticles using 3D flow focusing towards in vivo study JM Lim, N Bertrand, PM Valencia, M Rhee, R Langer, S Jon, ... Nanomedicine: Nanotechnology, Biology and Medicine 10 (2), 401-409, 2014 | 187 | 2014 |
| Nanoparticles with photoinduced precipitation for the extraction of pollutants from water and soil F Brandl, N Bertrand, EM Lima, R Langer Nature communications 6 (1), 1-10, 2015 | 123 | 2015 |
| Anti-polyethylene glycol antibodies alter the protein corona deposited on nanoparticles and the physiological pathways regulating their fate in vivo P Grenier, IM de Oliveira Viana, EM Lima, N Bertrand Journal of Controlled Release 287, 121-131, 2018 | 118 | 2018 |
| Solubilization of Docetaxel in Poly(ethylene oxide)-block-poly(butylene/styrene oxide) Micelles M Elsabahy, MÈ Perron, N Bertrand, G Yu, JC Leroux Biomacromolecules 8 (7), 2250-2257, 2007 | 94 | 2007 |
| Transmembrane pH-gradient liposomes to treat cardiovascular drug intoxication N Bertrand, C Bouvet, P Moreau, JC Leroux ACS nano 4 (12), 7552-7558, 2010 | 88 | 2010 |
| Pharmacokinetics and biodistribution of N-isopropylacrylamide copolymers for the design of pH-sensitive liposomes N Bertrand, JG Fleischer, KM Wasan, JC Leroux Biomaterials 30 (13), 2598-2605, 2009 | 85 | 2009 |
| New pharmaceutical applications for macromolecular binders N Bertrand, MA Gauthier, C Bouvet, P Moreau, A Petitjean, JC Leroux, ... Journal of controlled release 155 (2), 200-210, 2011 | 52 | 2011 |
| Modeling drug release from bioerodible microspheres using a cellular automaton N Bertrand, G Leclair, P Hildgen International journal of pharmaceutics 343 (1-2), 196-207, 2007 | 52 | 2007 |
| Innate and adaptive immune responses toward nanomedicines IM de Oliveira Viana, S Roussel, J Defrêne, EM Lima, F Barabé, ... Acta Pharmaceutica Sinica B, 2021 | 43 | 2021 |
| Insights into gold nanoparticles as a mucoadhesive system M Ouellette, F Masse, M Lefebvre-Demers, Q Maestracci, P Grenier, ... Scientific reports 8 (1), 1-15, 2018 | 43 | 2018 |
| Serum-stable, long-circulating, pH-sensitive PEGylated liposomes N Bertrand, P Simard, JC Leroux Liposomes, 545-558, 2010 | 41 | 2010 |
| Residual Solvents in Nanomedicine and Lipid-Based Drug Delivery Systems: a Case Study to Better Understand Processes A Dikpati, F Mohammadi, K Greffard, C Quéant, P Arnaud, G Bastiat, ... Pharmaceutical Research 37 (8), 1-11, 2020 | 35 | 2020 |
Omid FarokhzadSenior Lecturer (Previously Professor), Brigham & Women's Hospital and Harvard Medical School, USAEmail verificata su bwh.harvard.edu
